# REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation

> **NCT01353586** · PHASE2 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 186 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** nMARQ™ System

## Key facts

- **NCT ID:** NCT01353586
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-01
- **Primary completion:** 2013-09-01
- **Final completion:** 2013-09-01
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353586, "REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01353586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*